Information about BioConAct
My details
*
*
*

BioConAct (SRL)

Company information

Status
Active

Enterprise number

BE0745.917.924

VAT liability
Yes
Established
09-04-2020
Last balance sheet year
2025
Company size
Micro 0 FTE
Legal form
Société à responsabilité limitée (SRL)
Principal activity
Public relations and communication activities
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

7-day free trial, no credit card required.

Financial data from BioConAct

2025 2024 2023 2022
Income statement
Profit/Loss € 44,246 106% € 21,495 -27% € 29,503 -8% € 32,050
Gross margin € 36,693 20% € 30,574 -44% € 54,264 31% € 41,336
Balance sheet
Balance sheet total € 176,317 3% € 171,304 20% € 142,448 29% € 110,080
Equity € 44,346 -13% € 51,098 -54% € 110,141 37% € 80,638
Debts € 131,972 10% € 120,206 272% € 32,307 10% € 29,442

Publications from BioConAct

Date Publication
31-08-2022 Miscellaneous - Resignations - Appointments (NL)
14-04-2020 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of BioConAct?
The VAT number of BioConAct is BE 0745.917.924.
Wat is the PEPPOL ID of BioConAct?
The PEPPOL ID of BioConAct is 0208:0745917924. Log in or start a free trial to see the full overview.
When was BioConAct founded?
BioConAct was founded on 09-04-2020.
What is the address of BioConAct?
The current registered office of BioConAct is located at Kurs 6, 9831 Sint-Martens-Latem.
When was the last time BioConAct filed their annual financial statements?
The most recent financial statements of BioConAct were filed on 17-09-2026.
How many employees does BioConAct have?
There are currently no employees working at BioConAct or no workforce information is available.
What is the annual turnover of BioConAct?
At the time of its most recent financial statements, BioConAct did not publish any turnover figures. BioConAct reported a gross margin of €36,693.06.